Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Tandem Diabetes Care's ebitda for the twelve months ending Jun 30, 2026 was -$27.83M. For fiscal 2025 it was -$169.59M. The highest annual figure on record is $36.50M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$169.59M | – |
| FY2024 | Dec 31, 2024 | -$82.52M | – |
| FY2023 | Dec 31, 2023 | -$217.52M | – |
| FY2022 | Dec 31, 2022 | -$78.52M | -315.1% |
| FY2021 | Dec 31, 2021 | $36.50M | +1363.4% |
| FY2020 | Dec 31, 2020 | $2.49M | – |
| FY2019 | Dec 31, 2019 | -$10.65M | – |
| FY2018 | Dec 31, 2018 | -$38.81M | – |
| FY2017 | Dec 31, 2017 | -$56.08M | – |
| FY2016 | Dec 31, 2016 | -$72.56M | – |
| FY2015 | Dec 31, 2015 | -$64.18M | – |
| FY2014 | Dec 31, 2014 | -$71.28M | – |
| FY2013 | Dec 31, 2013 | -$46.27M | – |
| FY2012 | Dec 31, 2012 | -$31.02M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.32M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.93M | – |
| Q4 FY2025 | Dec 31, 2025 | $12.79M | +249.0% |
| Q3 FY2025 | Sep 30, 2025 | -$18.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$47.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$116.57M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.66M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.88M | – |
| Q2 FY2024 | Jun 30, 2024 | -$26.67M | – |
| Q1 FY2024 | Mar 31, 2024 | -$37.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$31.03M | – |
| Q3 FY2023 | Sep 30, 2023 | -$27.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$34.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$124.42M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.14M | -186.9% |
| Q3 FY2022 | Sep 30, 2022 | -$43.99M | -495.5% |
| Q2 FY2022 | Jun 30, 2022 | -$8.69M | -197.9% |
| Q1 FY2022 | Mar 31, 2022 | -$11.71M | -4821.8% |
| Q4 FY2021 | Dec 31, 2021 | $16.26M | -26.4% |
| Q3 FY2021 | Sep 30, 2021 | $11.12M | +461.6% |
| Q2 FY2021 | Jun 30, 2021 | $8.87M | – |
| Q1 FY2021 | Mar 31, 2021 | $248.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $22.09M | +483.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.98M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.74M | – |
| Q4 FY2019 | Dec 31, 2019 | $3.79M | +86.7% |
| Q3 FY2019 | Sep 30, 2019 | -$4.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$357.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.56M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.03M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.25M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.59M | – |
| Q1 FY2018 | Mar 31, 2018 | -$13.99M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.45M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$17.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$19.80M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.87M | – |
| Q3 FY2016 | Sep 30, 2016 | -$27.12M | – |
See a number that looks wrong?